Summit Therapeutics shares rose 23.3% in pre-market trading after AstraZeneca said it will invest $2.0 billion to take a stake in Summit and to collaborate on oncology drug development.

2026-09-29

Summit Therapeutics shares rose 23.3% in pre-market trading after AstraZeneca said it will invest $2.0 billion to take a stake in Summit and to collaborate on oncology drug development.